Clinical Experience With Atovaquone: A New Drug for Treating Pneumocystis carinii Pneumonia

This publication has 16 references indexed in Scilit:

• Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected Men
  The Journal of Infectious Diseases, 1991
• Inhaled or Intravenous Pentamidine Therapy forPneumocystis cariniiPneumonia in AIDS
  Annals of Internal Medicine, 1990
• Pulmonary Infectious Complications of Human Immunodeficiency Virus Infection: Part II
  American Review of Respiratory Disease, 1990
• Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis
  Antimicrobial Agents and Chemotherapy, 1990
• Trimethoprim-Sulfamethoxazole Compared with Pentamidine for Treatment ofPneumocystis cariniiPneumonia in the Acquired Immunodeficiency Syndrome
  Annals of Internal Medicine, 1988
• Treatment of Infections Associated with Human Immunodeficiency Virus
  New England Journal of Medicine, 1988
• Trimetrexate for the Treatment ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987
• Trimethoprim-Sulfamethoxazole or Pentamidine forPneumocystis cariniiPneumonia in the Acquired Immunodeficiency Syndrome
  Annals of Internal Medicine, 1986
• Persistence of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome
  Chest, 1985
• PERSISTENCE OF PNEUMOCYSTIS-CARINII IN LUNG-TISSUE OF ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS TREATED FOR PNEUMOCYSTIS PNEUMONIA
  Published by Elsevier ,1984